Adalimumab in the treatment of refractory non-infectious scleritis: 6-month outcomesEmilia Bober, Ian Yeung, Edward Hindle et al.|Eye|2023Cited by 6
Oral immunosuppression practice for inflammatory eye disease: A one-year analysis of prescriptions at Moorfields Eye HospitalTasanee Braithwaite, Narciss Okhravi, Jason Delisser et al.|Unknown|2019Cited by 0